BI Asset Management Fondsmaeglerselskab A/S »

Halozyme Therapeutics shares owned by BI Asset Management Fondsmaeglerselskab A/S

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by BI Asset Management Fondsmaeglerselskab A/S from 13F filings

Historical chart of BI Asset Management Fondsmaeglerselskab A/S investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by BI Asset Management Fondsmaeglerselskab A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by BI Asset Management Fondsmaeglerselskab A/S

Quarter filed Position value Share count Share price at filing
2024-03-31 $593k 15k 40.68
2023-12-31 $4.7M 127k 36.96
2023-03-31 $127k 3.3k 38.12
2022-12-31 $196k 3.4k 56.93